Order Article Reprints

Ejtehadifar M, Zahedi S, Gameiro P, Cabeçadas J, da Silva MG, Beck HC, Carvalho AS, Matthiesen R. Meta-Analysis of MS-Based Proteomics Studies Indicates Interferon Regulatory Factor 4 and Nucleobindin1 as Potential Prognostic and Drug Resistance Biomarkers in Diffuse Large B Cell Lymphoma. Cells. 2023; 12(1):196. https://doi.org/10.3390/cells12010196

Ejtehadifar, Mostafa, Sara Zahedi, Paula Gameiro, José Cabeçadas, Maria Gomes da Silva, Hans C. Beck, Ana Sofia Carvalho, and Rune Matthiesen. 2023. "Meta-Analysis of MS-Based Proteomics Studies Indicates Interferon Regulatory Factor 4 and Nucleobindin1 as Potential Prognostic and Drug Resistance Biomarkers in Diffuse Large B Cell Lymphoma" Cells 12, no. 1: 196. https://doi.org/10.3390/cells12010196

Ejtehadifar, M., Zahedi, S., Gameiro, P., Cabeçadas, J., da Silva, M. G., Beck, H. C., Carvalho, A. S., & Matthiesen, R. (2023). Meta-Analysis of MS-Based Proteomics Studies Indicates Interferon Regulatory Factor 4 and Nucleobindin1 as Potential Prognostic and Drug Resistance Biomarkers in Diffuse Large B Cell Lymphoma. Cells, 12(1), 196. https://doi.org/10.3390/cells12010196